125 related articles for article (PubMed ID: 37574315)
41. Antibacterial and Anti-Biofilm Activities of Silver Nano Particles Conjugated to Chitosan Against Multi-Drug Resistant Bacteria.
Mohammadinejat M; Sepahi AA; Alipour E
Clin Lab; 2023 Jan; 69(1):. PubMed ID: 36649516
[TBL] [Abstract][Full Text] [Related]
42. Telavancin demonstrates activity against methicillin-resistant Staphylococcus aureus isolates with reduced susceptibility to vancomycin, daptomycin, and linezolid in broth microdilution MIC and one-compartment pharmacokinetic/pharmacodynamic models.
Smith JR; Barber KE; Hallesy J; Raut A; Rybak MJ
Antimicrob Agents Chemother; 2015 Sep; 59(9):5529-34. PubMed ID: 26124162
[TBL] [Abstract][Full Text] [Related]
43. Synthesis, characterization, and antibacterial activities of a heteroscorpionate derivative platinum complex against methicillin-resistant
Nam-Cha SH; Domínguez-Jurado E; Tinoco-Valencia SL; Pérez-Tanoira R; Morata-Moreno N; Alfaro-Ruiza R; Lara-Sánchez A; Esteban J; Luján R; Alonso-Moreno C; Seguí P; Ocaña A; Gónzalez ÁL; Aguilera-Correa JJ; Pérez-Martínez FC; Alarcón MM
Front Cell Infect Microbiol; 2023; 13():1100947. PubMed ID: 37051297
[No Abstract] [Full Text] [Related]
44. Untargeted lipidomic differences between clinical strains of methicillin-sensitive and methicillin-resistant
Nikolic P; Mudgil P; Harman DG; Whitehall J
Infect Dis (Lond); 2022 Jul; 54(7):497-507. PubMed ID: 35277120
[TBL] [Abstract][Full Text] [Related]
45. Fabrication of Co-Assembly from Berberine and Tannic Acid for Multidrug-Resistant Bacteria Infection Treatment.
Zheng T; Chen H; Wu C; Wang J; Cui M; Ye H; Feng Y; Li Y; Dong Z
Pharmaceutics; 2023 Jun; 15(7):. PubMed ID: 37513970
[TBL] [Abstract][Full Text] [Related]
46. The synergy of berberine chloride and totarol against Staphylococcus aureus grown in planktonic and biofilm cultures.
Guo N; Zhao X; Li W; Shi C; Meng R; Liu Z; Yu L
J Med Microbiol; 2015 Aug; 64(8):891-900. PubMed ID: 26272283
[TBL] [Abstract][Full Text] [Related]
47. Effects of antibacterial mineral leachates on the cellular ultrastructure, morphology, and membrane integrity of Escherichia coli and methicillin-resistant Staphylococcus aureus.
Otto CC; Cunningham TM; Hansen MR; Haydel SE
Ann Clin Microbiol Antimicrob; 2010 Sep; 9():26. PubMed ID: 20846374
[TBL] [Abstract][Full Text] [Related]
48. Design, synthesis and antibacterial activity of chalcones against MSSA and MRSA planktonic cells and biofilms.
Garcia MAR; Theodoro RS; Sardi JCO; Santos MB; Ayusso GM; Pavan FR; Costa AR; Santa Cruz LM; Rosalen PL; Regasini LO
Bioorg Chem; 2021 Nov; 116():105279. PubMed ID: 34509799
[TBL] [Abstract][Full Text] [Related]
49. In vitro antimicrobial activity of ozenoxacin against methicillin-susceptible Staphylococcus aureus, methicillin-resistant S. aureus and Streptococcus pyogenes isolated from clinical cutaneous specimens in Japan.
Kanayama S; Ikeda F; Okamoto K; Nakajima A; Matsumoto T; Ishii R; Amano A; Matsuzaki K; Matsumoto S
J Infect Chemother; 2016 Oct; 22(10):720-3. PubMed ID: 27091753
[TBL] [Abstract][Full Text] [Related]
50. Vancomycin MIC susceptibility testing of methicillin-susceptible and methicillin-resistant Staphylococcus aureus isolates: a comparison between Etest® and an automated testing method.
Bland CM; Porr WH; Davis KA; Mansell KB
South Med J; 2010 Nov; 103(11):1124-8. PubMed ID: 20890258
[TBL] [Abstract][Full Text] [Related]
51. The synthesis and antistaphylococcal activity of 9, 13-disubstituted berberine derivatives.
Wang J; Yang T; Chen H; Xu YN; Yu LF; Liu T; Tang J; Yi Z; Yang CG; Xue W; Yang F
Eur J Med Chem; 2017 Feb; 127():424-433. PubMed ID: 28092858
[TBL] [Abstract][Full Text] [Related]
52. Novel chitosan-based pH-responsive lipid-polymer hybrid nanovesicles (OLA-LPHVs) for delivery of vancomycin against methicillin-resistant Staphylococcus aureus infections.
Hassan D; Omolo CA; Fasiku VO; Mocktar C; Govender T
Int J Biol Macromol; 2020 Mar; 147():385-398. PubMed ID: 31926237
[TBL] [Abstract][Full Text] [Related]
53. Evaluating the antibacterial activity of ceftaroline against clinical isolates of methicillin-susceptible and- resistant Staphylococcus aureus in Kuwait hospitals.
Alfouzan W; Boswihi SS; Dhar R; Udo E
J Infect Public Health; 2020 Oct; 13(10):1589-1591. PubMed ID: 32859552
[TBL] [Abstract][Full Text] [Related]
54. Isojacareubin from the Chinese herb Hypericum japonicum: potent antibacterial and synergistic effects on clinical methicillin-resistant Staphylococcus aureus (MRSA).
Zuo GY; An J; Han J; Zhang YL; Wang GC; Hao XY; Bian ZQ
Int J Mol Sci; 2012; 13(7):8210-8218. PubMed ID: 22942699
[TBL] [Abstract][Full Text] [Related]
55. More accurate measurement of vancomycin minimum inhibitory concentration indicates poor outcomes in meticillin-resistant Staphylococcus aureus bacteraemia.
Shoji H; Maeda M; Shirakura T; Takuma T; Ugajin K; Fukuchi K; Ishino K; Niki Y
Int J Antimicrob Agents; 2015 Nov; 46(5):532-7. PubMed ID: 26364848
[TBL] [Abstract][Full Text] [Related]
56. Ultrastructural changes in methicillin-resistant Staphylococcus aureus (MRSA) induced by a novel cyclic peptide ASP-1 from Bacillus subtilis: A scanning electron microscopy (SEM) study.
Deshmukh R; Chalasani AG; Chattopadhyay D; Roy U
Rev Argent Microbiol; 2021; 53(4):281-286. PubMed ID: 33608109
[TBL] [Abstract][Full Text] [Related]
57. Serrapeptase impairs biofilm, wall, and phospho-homeostasis of resistant and susceptible Staphylococcus aureus.
Katsipis G; Pantazaki AA
Appl Microbiol Biotechnol; 2023 Feb; 107(4):1373-1389. PubMed ID: 36635396
[TBL] [Abstract][Full Text] [Related]
58. Methicillin-resistant Staphylococcus aureus (MRSA) staphylococcal cassette chromosome mec genotype effects outcomes of patients with healthcare-associated MRSA bacteremia independently of vancomycin minimum inhibitory concentration.
Chen SY; Liao CH; Wang JL; Chiang WC; Lai MS; Chie WC; Chen WJ; Chang SC; Hsueh PR
Clin Infect Dis; 2012 Nov; 55(10):1329-37. PubMed ID: 22911641
[TBL] [Abstract][Full Text] [Related]
59. N-terminally modified linear and branched spermine backbone dipeptidomimetics against planktonic and sessile methicillin-resistant Staphylococcus aureus.
Dewangan RP; Joshi S; Kumari S; Gautam H; Yar MS; Pasha S
Antimicrob Agents Chemother; 2014 Sep; 58(9):5435-47. PubMed ID: 24982082
[TBL] [Abstract][Full Text] [Related]
60. Investigation of Morchella esculenta and Morchella conica for their antibacterial potential against methicillin-susceptible Staphylococcus aureus, methicillin-resistant Staphylococcus aureus and Streptococcus pyogenes.
Haq FU; Imran M; Saleem S; Aftab U; Ghazal A
Arch Microbiol; 2022 Jun; 204(7):391. PubMed ID: 35699800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
